Randy Strong

18.7k total citations · 5 hit papers
130 papers, 13.8k citations indexed

About

Randy Strong is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Randy Strong has authored 130 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 41 papers in Physiology and 40 papers in Cellular and Molecular Neuroscience. Recurrent topics in Randy Strong's work include Genetics, Aging, and Longevity in Model Organisms (35 papers), Neuroscience and Neuropharmacology Research (17 papers) and Stress Responses and Cortisol (15 papers). Randy Strong is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (35 papers), Neuroscience and Neuropharmacology Research (17 papers) and Stress Responses and Cortisol (15 papers). Randy Strong collaborates with scholars based in United States, United Kingdom and Canada. Randy Strong's co-authors include Arlan Richardson, James F. Nelson, Richard A. Miller, Nancy L. Nadon, Martin A. Javors, Elizabeth Fernández, Z. Dave Sharp, Clinton M. Astle, Kevin Flurkey and John E. Wilkinson and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Randy Strong

129 papers receiving 13.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

2009 2.8k citations Randy Strong, Z. Dave Sharp et al. profile →
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

2010 807 citations Patricia Spilman, Natalia Podlutskaya et al. PLoS ONE profile →
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau

2010 713 citations Antonella Caccamo, Smita Majumder et al. profile →
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice

2010 686 citations Richard A. Miller, Clinton M. Astle et al. The Journals of Gerontology Series A profile →
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging

2003 587 citations James F. Nelson, Randy Strong et al. profile →

Peers

Countries citing papers authored by Randy Strong

Since Specialization

Citations

This map shows the geographic impact of Randy Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Strong more than expected).

Fields of papers citing papers by Randy Strong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Strong. The network helps show where Randy Strong may publish in the future.

Co-authorship network of co-authors of Randy Strong

This figure shows the co-authorship network connecting the top 25 collaborators of Randy Strong. A scholar is included among the top collaborators of Randy Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy Strong. Randy Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of primary osteoarthritis during aging in genetically diverse UM-HET3 mice 2024 ·Arthritis Research & Therapy ·Sher Bahadur Poudel, Ryan Richard Ruff, (unknown), Richard A. Miller, David Harrison, Randy Strong, Thorsten Kirsch, Shoshana Yakar	6
2	Prepubertal castration eliminates sex differences in lifespan and growth trajectories in genetically heterogeneous mice 2023 ·Aging Cell ·(unknown), Catherine Cheng, Jonathan Gelfond, Randy Strong, Vivian Diaz, James F. Nelson	11
3	DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease 2023 ·npj Parkinson s Disease ·Anna Masato, Nicoletta Plotegher, (unknown), Michele Sandre, Gaia Faustini, Andrea Thor, Stephen Adams, (unknown), Susanna Cogo, (unknown), (unknown), Paul Anthony Martinez, Randy Strong, Rina Bandopadhyay, Marco Bisaglia, Arianna Bellucci, Elisa Greggio, Luisa Dalla Valle, Daniela Boassa, Luigi Bubacco	28
4	Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice 2019 ·BMC Microbiology ·Byron J. Smith, Richard A. Miller, Aaron C. Ericsson, David C. Harrison, Randy Strong, Thomas M. Schmidt	243
5	Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction 2013 ·Aging Cell ·Richard A. Miller, David E. Harrison, Clinton M. Astle, Elizabeth Fernández, Kevin Flurkey, Melissa Han, Martin A. Javors, Xinna Li, Nancy L. Nadon, James F. Nelson, Scott D. Pletcher, Adam B. Salmon, Z. Dave Sharp, (unknown), (unknown), Randy Strong	430
6	eRapa Restores a Normal Life Span in a FAP Mouse Model 2013 ·Cancer Prevention Research ·Paul Hasty, Carolina B. Livi, Sherry G. Dodds, D.R. Jones, Randy Strong, Martin A. Javors, Kathleen E. Fischer, Lauren Sloane, Kruthi Murthy, Gene B. Hubbard, Lishi Sun, Vincent Hurez, Tyler J. Curiel, Z. Dave Sharp	56
7	Rapamycin slows aging in mice 2012 ·Aging Cell ·John E. Wilkinson, (unknown), Susan V. Brooks, Chi‐Chao Chan, Sabrina Friedline, (unknown), J. Fielding Hejtmancik, Nancy L. Nadon, Randy Strong, (unknown), Maria A. Woodward, Richard A. Miller	498
8	Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease 2011 ·PLoS ONE ·Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale E. Bredesen, Arlan Richardson, Randy Strong, Verónica Galván	2
9	Lifelong rapamycin administration ameliorates age‐dependent cognitive deficits by reducing IL‐1β and enhancing NMDA signaling 2011 ·Aging Cell ·Smita Majumder, Antonella Caccamo, David X. Medina, Adriana D. Benavides, Martin A. Javors, Ellen Kraig, Randy Strong, Arlan Richardson, Salvatore Oddo	159
10	The Role of mTOR Signaling in Controlling Mammalian Life Span: What a Fungicide Teaches Us About Longevity 2010 ·The Journals of Gerontology Series A ·Z. Dave Sharp, Randy Strong	40
11	Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice breakdown → 2010 ·The Journals of Gerontology Series A ·Richard A. Miller, (unknown), Clinton M. Astle, Joseph A. Baur, Angela R. Boyd, Rafael de Cabo, Elizabeth Fernández, Kevin Flurkey, Martin A. Javors, James F. Nelson, Carlos J. Orihuela, Scott D. Pletcher, Z. Dave Sharp, David Sinclair, Joseph W. Starnes, John E. Wilkinson, Nancy L. Nadon, Randy Strong	686
12	Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease breakdown → 2010 ·PLoS ONE ·Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale E. Bredesen, Arlan Richardson, Randy Strong, Verónica Galván	807
13	Effects of anabolic androgenic steroids and social subjugation on behavior and neurochemistry in male rats 2010 ·Pharmacology Biochemistry and Behavior ·(unknown), Augustus R. Lumia, Elizabeth Fernández, Randy Strong, James L. Roberts, Marilyn Y. McGinnis	8
14	Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice 2008 ·Aging Cell ·Randy Strong, Richard A. Miller, Clinton M. Astle, Robert A. Floyd, Kevin Flurkey, Kenneth Hensley, Martin A. Javors, Christiaan Leeuwenburgh, James F. Nelson, Ennio Ongini, Nancy L. Nadon, Huber R. Warner, (unknown)	248
15	Cloning and characterization of a testis and brain-specific isoform of mouse 3′-phosphoinositide-dependent protein kinase-1, mPDK-1β 2002 ·Biochemical and Biophysical Research Communications ·Lily Dong, Fresnida J. Ramos, Michael J. Wick, (unknown), (unknown), Randy Strong, Arlan Richardson, Feng Liu	10
16	Identification of a glucocorticoid‐responsive element in the promoter region of the mouse tyrosine hydroxylase gene 2001 ·Journal of Neurochemistry ·(unknown), W. W. Morgan, N Elango, Randy Strong	42
17	A tetracycline-repressible transactivator approach suggests a shorter half-life for tyrosine hydroxylase mRNA 2001 ·Brain Research Protocols ·(unknown), Randy Strong, W. W. Morgan	7
18	Modulation of tyrosine hydroxylase gene expression in the rat adrenal gland by exercise: effects of age 1992 ·Molecular Brain Research ·Nihal Tümer, Charles R. Hale, James V. Lawler, Randy Strong	33
19	Regionally Selective Manifestations of Neostriatal Aging 1988 ·Annals of the New York Academy of Sciences ·Randy Strong	14
20	Modulation of Age-Related Changes in Serum 1,25-Dihydroxyvitamin D and Parathyroid Hormone by Dietary Restriction of Fischer 344 Rats 1988 ·Journal of Nutrition ·H. J. Armbrecht, Randy Strong, M. A. Boltz, (unknown), W. Gibson Wood, Arlan Richardson	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact